18 results found
Would a one-size-fits-all booster policy be a sound decision in the long run?
Scientific progress against emerging threats will matter only if societies can defend trust in evidence from the distortions of the post-truth age
Multiple molecular checks ensure that the COVID-19 vaccine does not affect human DNA, thus, the chances of this occurring are highly improbable
.png)
Various vaccine trials across the world are showing highly promising efficacy, and multiple vaccines are getting approved across continents. The global vaccine race has now entered its second phase, where countries try and procure as many doses of Covid-19 vaccines as possible. India has put its faith primarily in the vaccines of Oxford-AstraZeneca and Bharat Biotech-ICMR. It has also secured future stockpiles of Gamaleya and Novavax vaccines thr
Direct criticism for scarce or expensive vaccines at the government, not the private sector
कोविड-19 चा फैलाव आणखी रोखण्यासाठी एकाच प्रकारचे बूस्टर डोस देण्याचा निर्णय दीर्घकालीन उपाययोजनेच्या दृष्टीने योग्य आहे का ?
